VERUS CAPITAL PARTNERS, LLC

Position in ABUS — Arbutus Biopharma Corp

CIK 1796874 SCOTTSDALE, AZ

Position in ABUS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$73,200

+$4,575 QoQ

Shares Held

15,250

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#125

of 175 holders

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

VERUS CAPITAL PARTNERS, LLC holds $887,203 across 3 Biotechnology names. ABUS ranks #3 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SRRK	Scholar Rock Holding Corp	9,255	$509,025
2	REPL	Replimune Group, Inc.	27,550	$304,978
3	ABUS	Arbutus Biopharma Corp This page	15,250	$73,200

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$73,200	15,250	0.0%	Shares	Sole	2026-08-06
2026-03-31	$68,625	15,250	-8.4%	Shares	Sole	2026-05-22
2025-12-31	$80,086	16,650	0.0%	Shares	Sole	2026-02-11
2025-09-30	$75,591	16,650	+0.3%	Shares	Sole	2025-11-10
2025-06-30	$51,294	16,600	-1.2%	Shares	Sole	2025-08-07
2025-03-31	$58,632	16,800	-13.2%	Shares	Sole	2025-05-13
2024-12-31	$63,274	19,350	-28.1%	Shares	Sole	2025-02-05
2024-09-30	$103,565	26,900	-35.2%	Shares	Sole	2024-11-04
2024-06-30	$128,343	41,535	-1.0%	Shares	Sole	2024-08-01
2024-03-31	$108,192	41,935	+30.5%	Shares	Sole	2024-05-07
2023-12-31	$80,337	32,135	-3.0%	Shares	Sole	2024-02-09
2023-09-30	$67,264	33,135	-1.5%	Shares	Sole	2023-11-01
2023-06-30	$77,360	33,635	-2.9%	Shares	Sole	2023-07-31
2023-03-31	$104,944	34,635	+26.8%	Shares	Sole	2023-05-09
2022-12-31	$63,667	27,325	-1.4%	Shares	Sole	2023-02-14
2022-09-30	$52,907	27,700	-3.1%	Shares	Sole	2022-11-15
2022-03-31	$85,228	28,600	—	Shares	Sole	2022-08-09
No filing history on record for this holder in this stock.